Insider and congress filings

Humana Inc. (HUM)

NYSE · Healthcare · 330 insider filings · 119 congress trades · last filed 8 days agoS&P 500

1
Open-market insider filing shown
2d
Median delay on the insider filings
within the two business day rule
1/0
Purchases and sales in the filings shown

About Humana Inc.

from the company's filings and listing
Exchange
NYSE
Sector
Healthcare
Industry
Medical - Healthcare Plans
Chief executive
James A. Rechtin
Employees
67,060
Listed since
-
Market value
$48.0B
Price to earnings
37.6
Earnings per share
$10.63
Dividend yield
0.88%

www.humana.com

Earnings

6 reported quarters · next on Nov 6, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Jul 29, 2026$7.61$7.27$40.9B$40.6BEPS beatRevenue in line
Q1 FY2026reported Apr 29, 2026$10.31$10.24$39.6B$39.4BEPS in lineRevenue in line
Q4 FY2025reported Feb 11, 2026-$3.96-$4.00$32.5B$32.0BEPS in lineRevenue in line
Q3 FY2025reported Nov 5, 2025$3.24$2.93$32.6B$32.0BEPS beatRevenue beat
Q2 FY2025reported Jul 30, 2025$6.27$5.92$32.4B$31.9BEPS beatRevenue beat
Q1 FY2025reported Apr 30, 2025$11.58$10.07$32.1B$32.2BEPS beatRevenue in line

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for 2025 · proxy filed Mar 6, 2026
ExecutiveSalaryStock awardsOtherTotal
Celeste M. MelletChief Financial Officer$900K$10.7M$7.4M$18.9M
James A. RechtinPresident and Chief Executive Officer$1.3M$13.9M$3.5M$18.8M
Japan A. MehtaChief Information Officer$619K$3.9M$5.0M$9.6M
Michelle A. O’HaraChief Human Resources Officer$715K$4.9M$3.4M$8.9M
Sanjay K. Shetty, M.D.President, CenterWell$716K$5.1M$1.4M$7.2M

The summary compensation table from the 2025 proxy statement, current executives only. 1 executive who has since left the company is named in that filing and not shown here. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesChangeOf company
Dodge & Cox$4.3B10,940,380-3.9%9.10%
Blackrock, Inc.$4.1B10,417,803+2.1%8.67%
Vanguard Capital Management LLC$3.1B7,843,620+0.1%6.53%
Vanguard Portfolio Management LLC$2.3B5,818,956+0.2%4.84%
State Street Corp$2.2B5,457,072+0.1%4.54%
Pzena Investment Management LLC$1.7B4,403,136-19.5%3.66%
Massachusetts Financial Services Co$1.7B3,578,245-20.2%2.98%
Eagle Capital Management LLC$1.5B3,846,762+29.6%3.20%
Sessa Capital Im, L.P.$1.5B3,727,7400.0%3.10%
Geode Capital Management, LLC$1.3B3,369,757+1.3%2.80%
Jpmorgan Chase & Co$1.3B3,234,637+6.6%2.69%
FMR LLC$1.2B2,913,763+2.8%2.42%

A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.

Know the moment the next HUM filing lands.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Open-market insider trades

1 filing of 330 on record
InsiderActionSharesPriceValueTrade dateDelay
Sanjay K. ShettyPresident, CenterwellBought810$185.21$150KFeb 23, 20262d

One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.

Congress trades in HUM

20 disclosures of 119 on record · median 27d of the 45 allowed
MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Alan ArmstrongSelfFiled lateStockPurchase$1,001 - $15,000+136.6%S&P +20.2% · vs S&P 500 +116.4%Mar 27, 2026Jul 21, 2026116d
Michael T. McCaulStockPurchase$1,001 - $15,000+62.3%S&P +4.4% · vs S&P 500 +57.9%May 7, 2026Jun 10, 202634d
Michael T. McCaulStockPurchase$1,001 - $15,000+68.6%S&P +6.3% · vs S&P 500 +62.2%May 4, 2026Jun 10, 202637d
Ro KhannaStockPurchase$1,001 - $15,000+103.3%S&P +11.6% · vs S&P 500 +91.7%Apr 13, 2026May 11, 202628d
Michael T. McCaulStockPurchase$1,001 - $15,000+108.8%S&P +12.4% · vs S&P 500 +96.4%Apr 10, 2026May 4, 202624d
Ro KhannaStockPurchase$1,001 - $15,000+135.1%S&P +16.0% · vs S&P 500 +119.2%Mar 23, 2026Apr 7, 202615d
Julia LetlowStockSale$1,001 - $15,000+120.6%S&P +10.1% · vs S&P 500 +110.5%Feb 10, 2026Mar 12, 202630d
Michael T. McCaulStockSale$50,001 - $100,000+116.8%S&P +11.8% · vs S&P 500 +105.1%Feb 17, 2026Mar 10, 202621d
Ro KhannaStockSale$1,001 - $15,000+116.2%S&P +11.6% · vs S&P 500 +104.6%Feb 17, 2026Mar 9, 202620d
Ro KhannaStockSale$1,001 - $15,000+129.1%S&P +10.9% · vs S&P 500 +118.2%Feb 24, 2026Mar 9, 202613d
Ro KhannaStockSale$1,001 - $15,000+103.4%S&P +9.8% · vs S&P 500 +93.6%Jan 29, 2026Feb 6, 20268d
Julia LetlowFiled lateStockPurchase$1,001 - $15,000+50.4%S&P +19.9% · vs S&P 500 +30.6%Aug 8, 2025Jan 13, 2026158d
Gilbert Ray Cisneros, Jr.StockSale$1,001 - $15,000+66.3%S&P +11.6% · vs S&P 500 +54.8%Nov 12, 2025Dec 15, 202533d
Michael T. McCaulStockSale$15,001 - $50,000+42.3%S&P +13.0% · vs S&P 500 +29.3%Nov 4, 2025Dec 9, 202535d
Lisa C. McClainSpouseStockSale$1,001 - $15,000+44.2%S&P +12.0% · vs S&P 500 +32.2%Oct 31, 2025Nov 21, 202521d
Lisa C. McClainSpouseStockSale$1,001 - $15,000+40.5%S&P +12.3% · vs S&P 500 +28.2%Oct 30, 2025Nov 21, 202522d
Lisa C. McClainSpouseStockPurchase$1,001 - $15,000+40.6%S&P +13.2% · vs S&P 500 +27.4%Oct 30, 2025Nov 21, 202522d
Michael T. McCaulStockSale$15,001 - $50,000+37.2%S&P +11.4% · vs S&P 500 +25.8%Oct 27, 2025Nov 10, 202514d
Lisa C. McClainSpouseStockPurchase$1,001 - $15,000+57.7%S&P +15.7% · vs S&P 500 +41.9%Sep 25, 2025Oct 22, 202527d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000+57.2%S&P +21.4% · vs S&P 500 +35.8%Aug 5, 2025Sep 12, 202538d

Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.

Awards, option exercises and gifts (20)
InsiderEventSharesDate
Shantanu NundyChief Medical OfficerStock award2,549Sep 1, 2026
Paul John SmithDirectorStock award544Aug 1, 2026
Frederick John CrawfordDirectorStock award544Aug 1, 2026
Kurt J. HilzingerDirectorStock award233Jun 30, 2026
Robert Stuart FieldDirectorStock award852May 1, 2026
Joseph C. VenturaChief Legal OfficerStock award10,318May 1, 2026
Sanjay K. ShettyPresident, CenterwellStock award9,945May 1, 2026
Aaron MartinPresident, Medicare AdvantageStock award8,206May 1, 2026
David DintenfassPresident, Enterprise GrowthStock award11,273May 1, 2026
Japan MehtaChief Information OfficerStock award9,448May 1, 2026
Celeste MelletChief Financial OfficerStock award15,387May 1, 2026
James A. RechtinPresident & CEOStock award35,633May 1, 2026
Michelle A. O'HaraChief Human Resources OfficerStock award10,485May 1, 2026
Sanjay K. ShettyPresident, CenterwellTax withholding401Apr 1, 2026
Sanjay K. ShettyPresident, CenterwellOption exercise887Apr 1, 2026
George Renaudin IIPresident, InsuranceOther (see filing)25Mar 31, 2026
Kurt J. HilzingerDirectorStock award536Mar 31, 2026
Joseph C. VenturaChief Legal OfficerTax withholding478Feb 24, 2026
George Renaudin IIPresident, InsuranceOption exercise1,035Feb 24, 2026
George Renaudin IIPresident, InsuranceTax withholding419Feb 24, 2026

Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.

Questions

Are insiders buying or selling HUM?

Across the one open-market filing shown here, 1 was a purchase and 0 were sales.

Which members of Congress have traded HUM?

Alan Armstrong, Michael T. McCaul, Ro Khanna, Julia Letlow, Gilbert Ray Cisneros, Jr., Lisa C. McClain disclosed HUM transactions in the filings shown here.

Is HUM in the S&P 500 or the Nasdaq 100?

Humana Inc. is a current member of the S&P 500, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.

How quickly are HUM trades disclosed?

Insider filings on this page reached the public a median of 2 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 27 days, against the 45 the STOCK Act allows.

How to read a Form 4

A DECISION THE INSIDER MADE

POpen-market purchase. Bought with their own money at the market price.
SOpen-market sale. Sold on the market. A sale marked scheduled was set up in advance under a Rule 10b5-1 plan, often months before.

COMPENSATION PLUMBING

AStock award. Granted as pay, not bought.
MOption exercise. Converting options already held into shares.
FTax withholding. Shares handed back to the company to pay the tax on a grant.
GGift. Given away, with no money changing hands.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Sep 10, 2026.

Related companies

traded by the same members

See every company we track